lebrikizumab
eli lilly
['adhere trial', 'lebri,(-celebri)', 'derm']
adhere trial on efficacy and safety of lebrikizumab in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis, from , free to read online during #aad2023 
Home of @JAMA_Current, @JAMANetworkOpen, @JAMAHealthForum, & 10 specialty journals that publish science and opinion shaping #medicine today and into the future.